A Phase 2a, Randomised, Double-blind, Parallel Study to Assess the Efficacy, Safety and Tolerability of AZD9567 compared to Prednisolone 20 mg in patients with active Rheumatoid Arthritis (RA)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 31 Mar 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

05 Jun 2021 Primary endpoint has not been met. (Change from baseline in 28 joint Disease Activity Score using CRP (DAS 28 - CRP) at day 15 according to result presented at the 22nd Annual Congress of the European League Against Rheumatism
05 Jun 2021 Results assessing efficacy, safety and tolerability of AZD9567 with prednisolone in patients with active rheumatoid arthritis (RA), presented at the 22nd Annual Congress of the European League Against Rheumatism
03 Nov 2020 This trial has been discontinued in Netherlands, according to European Clinical Trials Database record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com